Cargando…

Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome

Accumulating evidence has implicated that berberine (BBR) has a beneficial effect on diabetic kidney disease (DKD), but its mechanism is not clear. The aim of this study was to assess whether berberine could alleviate tubulointerstitial fibrosis and attenuate epithelial-to-mesenchymal transition (EM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zejun, Zhu, Lili, Wang, Shangshang, Guo, Xin, Sun, Bei, Wang, Qilong, Chen, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154812/ https://www.ncbi.nlm.nih.gov/pubmed/35618411 http://dx.doi.org/10.1080/0886022X.2022.2079525

Ejemplares similares

Simiao pill inhibits epithelial mesenchymal transition in a mouse model of chronic hyperuricemic nephropathy by inhibiting NLRP3 inflammasome activation
por: Shui, Guangxing, et al.
Publicado: (2022)

Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
por: Lu, Miaomiao, et al.
Publicado: (2017)

The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
por: Alyaseer, Amani Abraheem Alsadiq, et al.
Publicado: (2020)

NLRP3-inflammasome activation is associated with epithelial-mesenchymal transition and progression of colorectal cancer
por: Marandi, Yasser, et al.
Publicado: (2021)

Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy
por: Lu, Qian, et al.
Publicado: (2019)

Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT/mTOR signaling pathway
por: Li, Jingpei, et al.
Publicado: (2021)

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
por: Qi, Hui-wei, et al.
Publicado: (2014)

The Role of NLRP3 Inflammasome in IgA Nephropathy
por: Wu, Xiaofang, et al.
Publicado: (2022)

Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice
por: Yang, Guannan, et al.
Publicado: (2017)

Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome
por: Zhou, Wei, et al.
Publicado: (2017)

Induction of Autophagy by Pterostilbene Contributes to the Prevention of Renal Fibrosis via Attenuating NLRP3 Inflammasome Activation and Epithelial-Mesenchymal Transition
por: Wang, Ying-Jan, et al.
Publicado: (2020)

EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption
por: Pinilla, Miriam, et al.
Publicado: (2023)

Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis
por: Tan, Yi-Fan, et al.
Publicado: (2020)

Lovastatin Alleviates Endothelial-to-Mesenchymal Transition in Glomeruli via Suppression of Oxidative Stress and TGF-β1 Signaling
por: Ma, Zejun, et al.
Publicado: (2017)

Berberine ameliorates aGVHD by gut microbiota remodelling, TLR4 signalling suppression and colonic barrier repairment for NLRP3 inflammasome inhibition
por: Zhao, Yanna, et al.
Publicado: (2022)

Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases
por: Sarbadhikary, Paromita, et al.
Publicado: (2021)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
por: Loeffler, Ivonne, et al.
Publicado: (2015)

MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017)

The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy
por: Williams, B. M., et al.
Publicado: (2022)

Berberine Inhibits the Metastatic Ability of Prostate Cancer Cells by Suppressing Epithelial-to-Mesenchymal Transition (EMT)-Associated Genes with Predictive and Prognostic Relevance
por: Liu, Chia-Hung, et al.
Publicado: (2015)

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2015)

Inactivation of RARβ inhibits Wnt1-induced mammary tumorigenesis by suppressing epithelial-mesenchymal transition
por: Liu, Xingxing, et al.
Publicado: (2014)

Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption
por: Qin, Zongshi, et al.
Publicado: (2023)

Psoralen Alleviates Renal Fibrosis by Attenuating Inflammasome-Dependent NLRP3 Activation and Epithelial–Mesenchymal Transition in a Mouse Unilateral Ureteral Obstruction Model
por: Lee, Tae Won, et al.
Publicado: (2023)

Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats
por: XIAO, XIAOYAN, et al.
Publicado: (2015)

Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
por: Yao, Mingjiang, et al.
Publicado: (2019)

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
por: Huang, Shuxuan, et al.
Publicado: (2021)

Berberine nanostructures attenuate ß-catenin, a key component of epithelial mesenchymal transition in lung adenocarcinoma
por: Malyla, Vamshikrishna, et al.
Publicado: (2023)

NLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
por: Tsai, Yu-Ling, et al.
Publicado: (2017)

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
por: Dong, Wenmin, et al.
Publicado: (2022)

Mangiferin from Pueraria tuberosa reduces inflammation via inactivation of NLRP3 inflammasome
por: Bulugonda, Ramakrishna K., et al.
Publicado: (2017)

Matrine suppresses breast cancer metastasis by targeting ITGB1 and inhibiting epithelial-to-mesenchymal transition
por: Ren, Lili, et al.
Publicado: (2020)

Resolvin D2 suppresses NLRP3 inflammasome by promoting autophagy in macrophages
por: Cao, Lijun, et al.
Publicado: (2021)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Electroacupuncture Alleviates Osteoarthritis by Suppressing NLRP3 Inflammasome Activation in Guinea Pigs
por: Wang, Zhankui, et al.
Publicado: (2020)

Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis
por: Hu, Yan, et al.
Publicado: (2022)

Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke
por: Yang-Wei Fann, D, et al.
Publicado: (2013)

The NLRP1 Inflammasome Induces Pyroptosis in Human Corneal Epithelial Cells
por: Griswold, Andrew R., et al.
Publicado: (2022)

Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c0krpufqk0t0cmiim0e8ahm0bp